
FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy
On Monday, July 21, a 10-member panel headed by Marty Makary, MD, MPH, commissioner of the FDA convened in Silver Spring, Maryland, to discuss the use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy. In his opening remarks, Makary …